Solutions For RealSolutions For Real
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Medicare Prior Authorization Getting WISeR? Five Essential Questions

July 23, 2025

11 Health Benefits of Walking Barefoot on Grass — According to Science

July 23, 2025

From Survival to Strategy: The Side Gig Economy Is Evolving

July 23, 2025
Facebook Twitter Instagram
Trending
  • Medicare Prior Authorization Getting WISeR? Five Essential Questions
  • 11 Health Benefits of Walking Barefoot on Grass — According to Science
  • From Survival to Strategy: The Side Gig Economy Is Evolving
  • OpenAI CEO Sam Altman Is Terrified About AI Bank Fraud
  • How To Slash The Burdens Of IRA Required Minimum Distributions
  • 15 Places That Are Swarming With Retirees — and Where They Are Fleeing
  • These Are the Remote Work Trends for 2025 — Including the Highest Paying Jobs
  • 10 Monthly Expenses That Don’t Make Sense Anymore
Wednesday, July 23
Facebook Twitter Instagram
Solutions For RealSolutions For Real
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Solutions For RealSolutions For Real
Home » DMK Pharmaceuticals Shares More Than Double on Canada Patent for Opioid
Investing

DMK Pharmaceuticals Shares More Than Double on Canada Patent for Opioid

News RoomBy News RoomSeptember 27, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

By Josh Beckerman

DMK Pharmaceuticals shares more than doubled, to $1.13, Tuesday as the company received a Canadian patent for an opioid intended to treat drug addiction.

Shares are down about 89% this year. The stock closed at 45 cents on Monday.

According to an abstract, the “present invention relates to a method of treating drug addiction and reducing dependence or tolerance on a dependence-inducing opiate drug.”

DMK was known as Adamis Pharmaceuticals until early September. The company sees several potential milestones for its lead clinical stage compound, DPI-125, by the end of 2024, such as the manufacture of a skin-based delivery system and the results of a safety study compared to fentanyl.

Write to Josh Beckerman at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Her High School Side Hustle Is On Track for 7-Figure Revenue

Investing July 22, 2025

Why Most Startups Fail to Get National Press — and What To Do Instead

Investing July 18, 2025

Your Brand Isn’t Broken — Your PR Strategy Is. Here’s What to Do Instead

Investing July 16, 2025

13 Behaviors People Find Condescending

Investing July 15, 2025

Manage Clients, Projects, and Sales Without Leaving Your Dashboard

Investing July 13, 2025

How Mastering Your Nervous System Boosts Leadership Presence and Performance

Investing July 12, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

11 Health Benefits of Walking Barefoot on Grass — According to Science

July 23, 20250 Views

From Survival to Strategy: The Side Gig Economy Is Evolving

July 23, 20250 Views

OpenAI CEO Sam Altman Is Terrified About AI Bank Fraud

July 23, 20250 Views

How To Slash The Burdens Of IRA Required Minimum Distributions

July 22, 20250 Views
Don't Miss

15 Places That Are Swarming With Retirees — and Where They Are Fleeing

By News RoomJuly 22, 2025

Lucigerma / Shutterstock.comAdvertising Disclosure: When you buy something by clicking links within this article, we…

These Are the Remote Work Trends for 2025 — Including the Highest Paying Jobs

July 22, 2025

10 Monthly Expenses That Don’t Make Sense Anymore

July 22, 2025

Billionaire In-N-Out Burger Heiress Moves Out of California

July 22, 2025
About Us
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

Medicare Prior Authorization Getting WISeR? Five Essential Questions

July 23, 2025

11 Health Benefits of Walking Barefoot on Grass — According to Science

July 23, 2025

From Survival to Strategy: The Side Gig Economy Is Evolving

July 23, 2025
Most Popular

Why People Leave Medicare Advantage Plans And Why It Matters To You

July 19, 20251 Views

After This 29-Year-Old Got Hooked on ChatGPT, He Built a ‘Simple’ Side Hustle Around the Bot That Brings In $4,000 a Month Dhanvin Siriam wanted to build something that made revenue from ChatGPT, and once he did, he says, “It just caught on.”

December 19, 20231 Views

Medicare Prior Authorization Getting WISeR? Five Essential Questions

July 23, 20250 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Solutions For Real. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.